|
|
||||||||


*
The Phagocyte Research Laboratory, Department of Medical Microbiology and Immunology,
Department of General and Marine Microbiology, University of Göteborg, Göteborg, Sweden; and
Department of Infectious Diseases, University of Linköping, Linköping, Sweden
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Binding of FMLP to the neutrophil FMLP receptor (FMLP-R) activates several signal transduction pathways (5, 10, 11). However, the precise signal(s) responsible for the subsequent activation of the NADPH-oxidase has not yet been identified. The amount of superoxide anion and hydrogen peroxide released upon neutrophil activation with FMLP is influenced not only by the degree of receptor exposure on the cell surface (12, 13) but also by the termination of the oxidase activity. The signals that lead to termination have not yet been defined. It has been suggested that the ability of the receptor-ligand complex to generate transmembrane signals is lost when the complex associates with the cytoskeleton, an event known to follow shortly after the binding of FMLP to its receptor. It has been convincingly shown that this cytoskeletal binding leads to desensitization of the receptor with respect to further activation by the agonist (14, 15, 16, 17). It has also been suggested that the coupling of the receptor-ligand complex to the cytoskeleton is responsible for the termination of an ongoing FMLP-induced NADPH-oxidase response (14, 15, 16).
It is well known that neutrophils that have mobilized their intracellular FMLP-R stores are "primed" with respect to FMLP-induced NADPH-oxidase activation. One mechanism behind this state must be an increased generation of second messengers that activate the NADPH-oxidase, but other regulatory mechanisms might also be of importance. The present study was performed to reveal whether priming following a rise in intracellular calcium is associated with a change in cytoskeleton-mediated regulation of FMLP receptor activity. The fact that desensitization was abolished in calcium ionophore-primed cells also made it possible to investigate the role of desensitization for the termination of the oxidative response.
| Materials and Methods |
|---|
|
|
|---|
Dextran and Ficoll-Pacque were purchased from Pharmacia (Uppsala, Sweden). FMLP, cytochalasin B, isoluminol, and Triton X-100 were obtained from Sigma (St. Louis, MO). Ionomycin was purchased from Calbiochem (La Jolla, CA). The phycoerythrin-conjugated mAb against CR3 was purchased from Becton Dickinson (San Jose, CA). The radiolabeled peptide [3H]FMLP was obtained from New England Nuclear (Boston, MA), and FITC-labeled formyl-Nle-Leu-Phe-Nle-Tyr-Lys (FITC-FNLPNTL)3 was from Molecular Probes (Eugene, OR).
Isolation of phagocytic cells
Blood neutrophils were isolated from heparinized whole blood or from buffy coats obtained from apparently healthy adults. After dextran sedimentation at 1 x g, hypotonic lysis of the remaining erythrocytes, and centrifugation in a Ficoll-Paque gradient (18), the neutrophils were washed twice and resuspended in Krebs-Ringer phosphate buffer containing glucose (10 mM), Ca2+ (1 mM), and Mg2+ (1.5 mM) (KRG, pH 7.3).
Exudated neutrophils were harvested from skin chambers placed on unroofed skin blister lesions on the volar surface of the forearms of healthy human volunteers, as previously described (19, 20). In each experiment, two chambers with three 0.6-ml wells covering the lesions were used. The chambers were filled with autologous serum, and the neutrophils were allowed to accumulate in the chambers for 24 h. More than 95% of the cells harvested from the chambers were neutrophils.
Measurement of neutrophil superoxide anion production
Neutrophil production of superoxide anion was assayed with an isoluminol-enhanced chemiluminescence (CL) system (21). The CL activity was measured in a six-channel Biolumat LB 9505 (Berthold Co., Wildbad, Germany), using disposable 4-ml polypropylene tubes with a reaction mixture of 0.9 ml containing 1 x 106 neutrophils, HRP (4 U), and isoluminol (a membrane-impermeable CL substrate, 2 x 10-5 M). This set-up measures the release of superoxide anion from the cells (21). The tubes were equilibrated for 5 min at 37°C, after which either the stimulus or, in some experiments, the cells were added. The light emission was recorded continuously. By a direct comparison of the SOD-inhibitable reduction of cytochrome c (using a millimolar extinction coefficient of 21.1 for cytochrome c (23, 24)) and SOD-inhibitable isoluminol-amplified CL, 7.3 x 107 counts were found to equal the production of 1 nmol of superoxide anion.
Mobilization of subcellular organelles
Neutrophil subcellular organelles were mobilized by treating the cells with ionomycin (22), a calcium-specific ionophore. After preincubating the cells for 5 min at 37°C, ionomycin (5 x 10-7 M final concentration) was added, and the incubation was continued for 5 min. The cells were then centrifuged, washed once, resuspended in KRG, and put on ice until used.
Desensitization
Neutrophils (107/ml) were incubated for 5 min at 15°C, FMLP (10-7 M final concentration) was added, and the incubation was continued for 10 min. The cells were then added (50100 µl) to prewarmed (37°C) CL vials containing isoluminol, HRP, and FMLP (10-7 M final concentration), and the production of superoxide anion was followed as described above.
Determinations of receptor exposure by FACS analysis
Neutrophils were fixed for 30 min in ice-cold paraformaldehyde (4% w/v in PBS).
To determine the exposure of CR3, 10 µl of a conjugated mAb was added
to a cell pellet (
100 µl) of 106 cells. The cells were
incubated on ice for 30 min, washed twice with KRG, and analyzed for
amount of cell bound probe (correlating to the amount of CR3) by flow
cytometry (FACScan; Becton Dickinson, Mountain View, CA).
To determine the exposure of FMLP-R, a FITC-conjugated formylated
peptide (FITC-FNLPNTL; 10-8 M final concentration) was
added to a cell pellet (
100 µl) of 106
paraformaldehyde-fixed cells in the absence or presence of an excess
amount (5 x 10-6 M) of nonlabeled FMLP. The cells
were incubated at 22°C for 30 min, and no washing was performed after
labeling. The amount of specifically bound probe (correlating to the
amount of FMLP-R) was determined by flow cytometry (23).
The cellular content of F-actin
The F-actin content in the neutrophils was analyzed by staining with fluorescein-phalloidin (Molecular Probes). The cells were fixed with paraformaldehyde (4% w/v in PBS), permeabilized with phosphatidylcholine, and incubated with FITC-phalloidin according to the instructions of the manufacturer. The cell content of F-actin was determined by flow cytometry.
Association of the ligand-receptor complex with the cytoskeleton
To determine the amount of receptor-ligand complex associated with the cytoskeleton, the cells were allowed to interact with FMLP at 15°C. Interaction with the peptide at 15°C permits binding of the ligand-receptor complexes to the cytoskeleton, but neither the mobilization of intracellular organelles nor the internalization of the receptor-ligand complex occurs (14, 24). Cytoskeletal fractions were prepared as described earlier (24). Briefly, the cells were incubated at 15°C for 5 min, after which [3H]FMLP (2 x 10-8 M) was added, either alone or together with an excess of nonradioactive FMLP (10-5 M), and the incubation was continued for an additional 10 min. The cells were pelleted and resuspended in an ice-cold buffer containing Triton X-100 (1% v/v). The samples were mixed and put on ice for 10 min, after which they were centrifuged for 20 s (9000 x g) in a Beckman microfuge (Beckman Instruments, Fullerton, CA). The Triton X-100-insoluble pellet was washed once in the same medium, and the radioactivity associated with the cytoskeleton was determined (24). No radioactivity was associated with the cytoskeleton (Triton X-100-insoluble pellet) when the peptide was introduced in the system 30 s after solubilization with Triton X-100.
| Results |
|---|
|
|
|---|
The chemoattractant peptide FMLP induced a very rapid neutrophil
response measured as superoxide anion production (Fig. 1
). The maximal production was reached
within the first minute, and the response was terminated within 3 to
4 min.
|
|
|
Neutrophils that were allowed to interact with the chemoattractant
FMLP at 15°C were desensitized (Fig. 4
), i.e., when these cells were
transferred to 37°C, they did not respond to FMLP. This
desensitization was stimulus specific. In fact, neutrophils
desensitized to FMLP were primed in response to fluoride ions
(presumably acting in conjunction with trace levels of aluminum), while
the PMA-induced response was unchanged (not shown). We as well as
others have shown earlier that binding of FMLP to its receptor at
15°C is associated neither with any granule secretion nor with
activation of the NADPH-oxidase (24, 25).
|
|
Desensitization in exudated neutrophils
The lack of desensitization (as well as the impaired anchoring of FMLP-occupied receptors to the cytoskeleton) in ionomycin-treated neutrophils could be explained if the receptors mobilized from the storage pools lacked the ability to become desensitized. To test this hypothesis, we determined the ability of exudated neutrophils to become desensitized.
Neutrophils exert their function in vivo mainly after extravasation, a
process associated with a hierarchical mobilization of the
intracellular storage organelles. In exudated neutrophils, all
secretory vesicles are mobilized together with
40% of the
gelatinase granules and 20% of the specific granules (8). The
extravasation process thus results in an increased surface expression
of various receptors, including the FMLP-R (19), and as a consequence,
such cells were primed with respect to the NADPH-oxidase activity
induced by FMLP (Fig. 6
).
|
|
Many FMLP-induced responses (including activation of the NADPH-oxidase) show transient kinetics. It has been suggested that the rapid termination of the responses occurs through the desensitization brought on by the coupling of the receptor-ligand complex to the cytoskeleton (14, 15, 16). To investigate whether this assumption holds true, we studied the kinetics (and thereby the termination) of the response in the primed cell populations (ionomycin-treated and exudated cells, respectively) that differ in ability to become desensitized.
We have shown earlier that the technique used to measure oxidase
activity (isoluminol/HRP CL) is well suited for real time studies of
superoxide anion release from activated neutrophils (21). In both
ionomycin-treated and exudated cells, the FMLP-induced response was
increased with respect to magnitude as well as to the duration of the
response (Figs. 1
and 6
). However, the kinetics of the production of
superoxide anion was roughly the same in these two cell populations,
irrespective of whether the cells were desensitizable (i.e., exudated
cells) or not (i.e., ionomycin-treated cells) (Table I
).
Hence, our results show that the
processes of desensitization and termination of oxidase activity in
response to FMLP are not linked.
|
| Discussion |
|---|
|
|
|---|
We know from earlier studies (22, 27, 28) that ionomycin induces a mobilization of neutrophil granules to the cell surface, resulting in an increased exposure of different receptors. To measure the amount of FMLP receptors on ionomycin-primed cells, FITC-labeled peptide was allowed to bind to the FMLP receptors, and the cells were analyzed by FACS without prior washing. This technique is superior to the technique previously used (both by us and others), which was based on binding of radioactively labeled peptides, since the latter required sedimentation and washing of the cells to remove unbound peptide. This latter treatment caused a partial detachment of bound ligand, resulting in an underestimation of binding. Furthermore, the characteristics of the binding in that system were such that it did not allow an extrapolation from the binding data of receptor number and binding affinity (29, 30, 31). The receptor binding data that we obtained, showing a very low binding to ionomycin-treated cells, using a protocol with a radiolabeled ligand and a brief washing procedure (not shown), and at the same time a high level of binding with the FITC-labeled ligand, suggest that the number of receptors are increased in these cells but that the dissociation constant is higher compared with the nontreated cells. Using high resolution binding data, it has been shown that the FMLP-R may exist in two interconverting forms (32, 33), one low affinity and one high affinity state. A detailed characterization of the receptor conversion is beyond the specific aims of the present work, which is focused on desensitization and termination of the NADPH-oxidase; however, our results fit with the suggestion that the conversion of the low affinity receptors to the high affinity state is missing in ionomycin-treated cells.
The degree of receptor exposure was higher in ionomycin-primed cells (shown also for the CR3 molecules that are stored in the same compartments as the FMLP-R (7)) compared with untreated control cells. We therefore conclude that the decrease in number of ligand-receptor complexes recovered in the Triton X-100-insoluble phase from ionomycin-primed cells is not due to a decrease in receptor exposure but rather to an impaired association of the ligand-receptor complexes with the cytoskeleton.
One way to fit our data into the model of desensitization would be to suggest that the newly mobilized receptors lack the ability to become desensitized. To investigate this possibility, we determined the FMLP response in neutrophils that had exudated from the blood stream, such cells having mobilized their intracellular pools of receptors (8). The fact that the exudated cells could be desensitized suggests that impaired desensitization is not due to a recruitment of new, nondesensitizable receptors. In addition, our results clearly show that the signals mediating desensitization are also generated in exudated neutrophils, i.e., in cells that have experienced an intimate contact with the vascular endothelium and the basement membrane and have been exposed to a large variety of inflammatory mediators present in the exudate.
The molecular mechanisms behind the lack of desensitization in
ionomycin-primed cells can only be speculated upon at this time. It has
been shown that an occupation of the receptor for complement fragment
5a triggers an association of the FMLP-R to the cytoskeleton (17),
indicating that the association of these receptors to the cytoskeleton
is not a process driven by ligand-induced changes of the receptor. It
has been suggested that the desensitization is due to an
actin-dependent/-driven segregation of the active ligand-receptor
complex from the amplifying G protein(s). A rise in intracellular
Ca2+ affects (directly or indirectly) the degree of actin
polymerization (Refs. 34 and 35; Fig. 3
) as well as the subcellular
distribution of other cytoskeleton proteins (36, 37), and an attractive
explanation for the phenomenon observed in ionomycin-primed cells is
that these changes secondarily interfere with/affect the capability of
the cytoskeleton to bind the occupied receptors. At the present time,
however, we can not exclude the possibility that the receptors as well
as the amplifying G protein(s) are affected by the rise in
intracellular calcium.
Binding of FMLP to its neutrophil surface receptors results in
superoxide anion production by the membrane-localized NADPH-oxidase,
but the active oxidase molecules are rapidly deactivated (38). A
sustained production of reactive oxygen species is thus a result of
continued production of second messengers, inducing a replenishment of
a small pool of active oxidase (38). According to the hypothesis
described above, association between the occupied receptors and the
cytoskeleton regulates the generation of activating signals and by that
the termination of the oxidase activity (14, 15, 16, 25). We compared the
time course of superoxide anion production in control cells and in the
two cell populations that were primed with respect to FMLP-induced
generation of reactive oxygen species. The time required to reach the
peak value was somewhat longer in the primed cells, as was the time for
the half-fall of the response (
T in Table I
). However, the small
changes in the kinetics of the response were not related to the
desensitization phenomenon, since they occurred not only in
ionomycin-treated cells but also in exudated cells. Taken together,
these data clearly show that the termination of the oxidase response to
FMLP is not linked to the desensitization process.
Our results support the concept that an association of the ligand-receptor complex with the cytoskeleton is linked to a desensitization of the neutrophils with respect to activation of the oxidase. Desensitization may be achieved through a direct interaction of the receptor-ligand complex with cytoskeleton proteins such as actin (16). A rise in intracellular Ca2+ affects the organization of the cytoskeleton (36, 37, 39, 40), and this should be expected to interfere with the desensitization process. With respect to the role of desensitization in the termination of FMLP-induced oxidase activity, the results presented here strongly imply the existence of an alternative, not yet identified mechanism that is responsible for the termination of the oxidase activity.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Li Liu, The Phagocyte Research Laboratory, Department of Medical Microbiology and Immunology, University of Göteborg, Guldhedsgatan 10, S-413 46 Göteborg, Sweden. ![]()
3 Abbreviations used in this paper: FNLPNTL, formyl-Nle-Leu-Phe-Nle-Tyr-Lys; HRP, horseradish peroxidase; CL, chemiluminescence; SOD, superoxide dismutase; KRG, Krebs-Ringer phosphate buffer containing glucose, Ca2+, and Mg2+; Mcpm, 106 counts per minute. ![]()
Received for publication December 5, 1996. Accepted for publication October 30, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. P. D. Volk, C. K. Heise, J. L. Hougen, C. M. Artman, K. A. Volk, D. Wessels, D. R. Soll, W. M. Nauseef, F. S. Lamb, and J. G. Moreland ClC-3 and IClswell are Required for Normal Neutrophil Chemotaxis and Shape Change J. Biol. Chem., December 5, 2008; 283(49): 34315 - 34326. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Forsman, E. Salomonsson, K. Onnheim, J. Karlsson, A. Bjorstad, H. Leffler, J. Bylund, A. Karlsson, and C. Dahlgren The {beta}-galactoside binding immunomodulatory lectin galectin-3 reverses the desensitized state induced in neutrophils by the chemotactic peptide f-Met-Leu-Phe: role of reactive oxygen species generated by the NADPH-oxidase and inactivation of the agonist Glycobiology, November 1, 2008; 18(11): 905 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Martner, C. Dahlgren, J. C. Paton, and A. E. Wold Pneumolysin Released during Streptococcus pneumoniae Autolysis Is a Potent Activator of Intracellular Oxygen Radical Production in Neutrophils Infect. Immun., September 1, 2008; 76(9): 4079 - 4087. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. D. McLaughlin, A. Banerjee, and C. C. Silliman Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation J. Leukoc. Biol., November 1, 2005; 78(5): 1025 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. VanCompernolle, K. L. Clark, K. A. Rummel, and S. C. Todd Expression and Function of Formyl Peptide Receptors on Human Fibroblast Cells J. Immunol., August 15, 2003; 171(4): 2050 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bylund, A. Bjorstad, D. Granfeldt, A. Karlsson, C. Woschnagg, and C. Dahlgren Reactivation of Formyl Peptide Receptors Triggers the Neutrophil NADPH-oxidase but Not a Transient Rise in Intracellular Calcium J. Biol. Chem., August 15, 2003; 278(33): 30578 - 30586. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Svensson, C. Dahlgren, and C. Wenneras The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1 J. Leukoc. Biol., October 1, 2002; 72(4): 810 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dahlgren, T. Christophe, F. Boulay, P. N. Madianos, M. J. Rabiet, and A. Karlsson The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptor Blood, March 1, 2000; 95(5): 1810 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Christophe, A. Karlsson, C. Dugave, M.-J. Rabiet, F. Boulay, and C. Dahlgren The Synthetic Peptide Trp-Lys-Tyr-Met-Val-Met-NH2 Specifically Activates Neutrophils through FPRL1/Lipoxin A4 Receptors and Is an Agonist for the Orphan Monocyte-expressed Chemoattractant Receptor FPRL2 J. Biol. Chem., June 8, 2001; 276(24): 21585 - 21593. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |